# Proof-of-concept Study of NSAID Hydrogel Patch in Treatment of Acute Pain

> **NCT02729207** · PHASE2 · TERMINATED · sponsor: **Teikoku Seiyaku Co., Ltd.** · enrollment: 6 (actual)

## Conditions studied

- Ankle Sprain

## Interventions

- **DRUG:** Esflurbiprofen Hydrogel Patch

## Key facts

- **NCT ID:** NCT02729207
- **Lead sponsor:** Teikoku Seiyaku Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-07
- **Primary completion:** 2016-12-21
- **Final completion:** 2016-12-27
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Due to lack of patients number
- **Last updated:** 2021-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02729207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02729207, "Proof-of-concept Study of NSAID Hydrogel Patch in Treatment of Acute Pain". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02729207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*